Skip to main content
. 1999 Jun 8;96(12):6925–6930. doi: 10.1073/pnas.96.12.6925

Table 1.

Growth inhibition of human cancer cells in vitro by doxorubicin and prodoxorubicin

Time, hr Treatment IC50, μM
HT29 LIM1215 LNCaP
72 doxorubicin 3.0 0.4 0.4
prodoxorubicin >25 18 18
120 doxorubicin 2.5 0.4 0.2
prodoxorubicin 22 10 8